SAINT PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results